APA

Distler O., Brown K. K., Distler J. H. W., Assassi S., Maher T. M., Cottin V., Varga J., Coeck C., Gahlemann M., Sauter W., Schmidt H. & Highland K. B. (20171221). Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). : Clinical and experimental rheumatology.

Chicago

Distler Oliver, Brown Kevin K, Distler Jörg H W, Assassi Shervin, Maher Toby M, Cottin Vincent, Varga John, Coeck Carl, Gahlemann Martina, Sauter Wiebke, Schmidt Hendrik and Highland Kristin B. 20171221. Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). : Clinical and experimental rheumatology.

Harvard

Distler O., Brown K. K., Distler J. H. W., Assassi S., Maher T. M., Cottin V., Varga J., Coeck C., Gahlemann M., Sauter W., Schmidt H. and Highland K. B. (20171221). Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). : Clinical and experimental rheumatology.

MLA

Distler Oliver, Brown Kevin K, Distler Jörg H W, Assassi Shervin, Maher Toby M, Cottin Vincent, Varga John, Coeck Carl, Gahlemann Martina, Sauter Wiebke, Schmidt Hendrik and Highland Kristin B. Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). : Clinical and experimental rheumatology. 20171221.